Short communication · 14 Apr 2025
Conference abstractPublished 17 Sep 2018
Role of galectin-3 in bone and fat cell differentiation: Implications for bone and adipose tissue development, metabolism and function
Sapienza University of Rome, Italy
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Galectin-3 is expressed in bone, where it is considered a marker of chondrogenic and osteogenic cell lineages. Moreover, we recently reported that galectin-3 modulates osteogenic transdifferentiation of vascular smooth muscle cells and is involved in the process of atherosclerotic calcification. This lectin is also expressed in human adipocytes during cell differentiation and its circulating levels are positively associated with human and murine obesity. Therefore, we decided to investigate the in vitro differentiating capacity of bone cells and adipocyte precursors from glectin-3 knockout (Lgals3-/-) mice, and the structural and functional phenotype of bones and fat depots of these mice. Regarding the bone, osteoblasts and osteoclasts precursors derived from Lgals3-/-mice showed impaired terminal differentiation, reduced mineralization capacity and resorption activity, which translated into profound alterations of bone remodeling and structure throughout life, resulting in accelerated agedependent bone loss and reduced bone strength. Regarding the adipose tissue, stromal precursor cells from Lgals3-/- mice showed defective adipocyte differentiation, as revealed by decreased expression of adipogenic markers and reduced ability to store lipids, which resulted in delayed maturation and function of adipose tissue in vivo. Adipose tissue dysfunction was associated with transient insulin resistance and inflammation at both the adipose tissue and systemic level, resulting in impaired glucose homeostasis. Therefore, these studies demonstrate that galectin-3 is a critical regulator of osteogenic and adipogenic differentiation, thus playing an important role in bone physiology and systemic energy metabolism. Overall, these findings identify galactin-3 as an attractive potential target to treat disorders of bone remodeling and energy metabolism.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Glycobiology.
Commentary · 11 Apr 2025
The Essential Role of Glycosylation in Biological Processes and Disease Pathogenesis
Commentary · 10 Apr 2025
Exploring the Secrets of Glycomics: Decoding the Complexities of Sugars
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Glycobiology
- SubjectDiabetes & Endocrinology
- SubjectObesity & Weight Management
- SubjectOrthopaedics
- BylineArticles whose byline prints “Giuseppe Pugliese”
